The 3rd In Vivo Cell Engineering and Gene Editing Summit covers topics such as:
Evaluating Promises & Challenges to Propel In Vivo Approaches as the Definitive Solution
Optimizing Target Specificity to Minimize Off-Target Toxicity & Prioritize Safety, Allowing Progression Towards Clinics
Finding the Balance Between Efficacy & Toxicity to Secure Safe & Promising Outcomes
Discussing Innovations in Platform Development: CAR-M Therapies & Administration Methods
Comparing Modes of Delivery: Viral vs Non-Viral, to Gain Insights into Transient & Permanent Delivery Methods
Driving In Vivo as the Frontier for Multiple Facets of Cell & Gene Therapy: Focusing on Gene Editing in the Liver & Other Tissues, & Cell Engineering Beyond Oncology
Spotlighting Companies Closest to the Clinic to Understand Priorities & Challenges at this Stage of Development
Venue
Colonnade Hotel ,
120 Huntington Avenue
, Boston, Massachusetts, United States
